Clinical Data

Pharma

AstraZeneca's Truqap falls short in another phase 3 trial

AstraZeneca has come up short in another phase 3 trial of Truqap, raising more questions about the blockbuster potential of the first-in-class drug.

Kevin Dunleavy Apr 29, 2025 3:26pm

merck

AACR: Keytruda delivers an industry first in head and neck cancer

Apr 28, 2025 1:28pm

Close up of horse legs and hooves running on sand track

J&J puts ImmunityBio on defense mode in bladder cancer

Apr 27, 2025 12:35pm

crash fall stock shares market economy down red arrow

Summit stock falls as Akeso shares bispecific OS data vs. Keytruda

Apr 25, 2025 4:02pm

lung cancer

Akeso's fast-rising ivonescimab scores 3rd lung cancer trial win

Apr 23, 2025 11:30am

BMS

BMS' schizophrenia drug stumbles in blow to blockbuster plan

Apr 23, 2025 10:35am